PROTO SCRIPT PHARMACEUTICAL CORP: 10-Q filed 2014-01-17

Name: PROTO SCRIPT PHARMACEUTICAL CORP: 10-Q filed 2014-01-17
Creator: PROTO SCRIPT PHARMACEUTICAL CORP

What PROTO SCRIPT PHARMACEUTICAL CORP reported in its quarterly report filed 2014-01-17 (fiscal Q2 2014): 16 published measures, 43 facts as tagged in accession 0001517126-14-000024.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-01-17
Fiscal period: fiscal Q2 2014
Accession: 0001517126-14-000024 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROTO SCRIPT PHARMACEUTICAL CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-11-30	36,022	USD
At 2013-05-31	47,044	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-11-30	8,141	USD
At 2013-05-31	7,524	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-11-30	27,881	USD
At 2013-05-31	39,520	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2013-11-30	35,022	USD
At 2013-05-31	46,044	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	-4,530	USD	91
2013-06-01 to 2013-11-30	-11,639	USD	183
2010-11-18 to 2013-11-30	-81,418	USD	1109
2012-09-01 to 2012-11-30	-12,960	USD	91
2012-06-01 to 2012-11-30	-20,114	USD	183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-06-01 to 2013-11-30	-11,022	USD	183
2010-11-18 to 2013-11-30	-73,277	USD	1109
2012-06-01 to 2012-11-30	-18,459	USD	183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2010-11-18 to 2013-11-30	109,299	USD	1109
2012-06-01 to 2012-11-30	78,000	USD	183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2010-11-18 to 2013-11-30	-1,000	USD	1109
2012-06-01 to 2012-11-30	-1,000	USD	183

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-11-30	4,282	USD
At 2013-05-31	2,524	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	4,530	USD	91
2013-06-01 to 2013-11-30	11,639	USD	183
2010-11-18 to 2013-11-30	81,418	USD	1109
2012-09-01 to 2012-11-30	12,960	USD	91
2012-06-01 to 2012-11-30	20,114	USD	183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-11-30	3,048,000	shares
At 2013-05-31	3,048,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-11-30	106,251	USD
At 2013-05-31	106,251	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-11-30	3,859	USD
At 2013-05-31	5,000	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-09-01 to 2013-11-30	74	USD	91
2013-06-01 to 2013-11-30	164	USD	183
2010-11-18 to 2013-11-30	2,400	USD	1109
2012-09-01 to 2012-11-30	183	USD	91
2012-06-01 to 2012-11-30	243	USD	183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2010-11-18 to 2013-11-30	104,000	USD	1109
2012-06-01 to 2012-11-30	78,000	USD	183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2013-06-01 to 2013-11-30	1,758	USD	183
2010-11-18 to 2013-11-30	4,282	USD	1109
2012-06-01 to 2012-11-30	2,497	USD	183

Inspect the source

Entity: PROTO SCRIPT PHARMACEUTICAL CORP / CIK 0001521420
Captured: 2026-09-23 02:58 UTC
SEC response SHA-256: 2d6a431860895eaf04449370cf49fbd69c1f3911caa847298374126c7f84f220

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001521420.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))